Novel Treatment Approach to Alzheimer’s Disease Uses Vitamin B1 Derivative
July 19, 2022
With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.
